Comparing Bimzelx and Skyrizi: a New Psoriatic Arthritis Showdown

In the world of psoriatic arthritis (PsA) treatments, a new head-to-head comparison has generated significant discussion. A recent study directly comparing Bimzelx and Skyrizi showed that for the primary goal of joint improvement, Bimzelx outperformed Skyrizi. This result is noteworthy as it marks the first time a treatment has demonstrated superiority over an IL-23 inhibitor […]
Energy Drinks and Mental Health

When researchers looked at people who drink a lot of coffee versus those who regularly reach for energy drinks, an interesting and concerning pattern showed up. Higher energy drink use was linked to a greater risk of suicidal thoughts and behaviors, especially among young men. That doesn’t mean energy drinks are the direct cause. This […]
The Real Economics Behind Cross-Border Pharmacy Programs

U.S. patients are struggling with already high and continuously rising brand-name drug prices. Prescription drug pricing in the United States has become one of the most visible pressure points in household healthcare spending. Brand-name medicines routinely cost several times more in the U.S. than in other advanced economies, even when the products are identical and […]
TrumpRx and the New Wave of Direct Drug Sales

The announcement by the U.S. federal government of a new plan to introduce direct-to-customer (DTC) access for medications has some serious implications for employers, brokers, and self-insured plan administrators. This article focuses on the likely effects of cost containment and strategic sourcing of the TrumpRx plans. The question remains: Do we know enough to claim that TrumpRx […]
Will TrumpRx Lower Your Prescription Costs? Here’s the Truth.

At the beginning of October 2025, the Trump administration announced plans for direct-to-consumer prescription drugs, called TrumpRx. Although facts are still hard to come by, it appears that at its core, TrumpRx and DTC, which is supposed to be launched sometime in 2026, is meant to create a government-run portal that will steer patients directly […]
GLP-1 Agonists: A Potential Game-Changer for Addictive Behavior

A complicated research paper was published just a few weeks ago on the Nature website that introduces some exciting new findings about how GLP-1 agonist medications like semaglutide, Ozempic, Mounjaro, Wegovy, and trizepatide may be capable of doing far more than just treating diabetes and obesity. One of the most impressive findings indicates that addictive […]
Five common misbeliefs about COVID-19 and vaccines

Do people let false claims about health issues get in their way? It is quite disturbing to learn that reliable research into public attitudes toward health reveals substantial misconceptions and willingness to believe false claims about health issues as “the whole truth.” One of these research efforts was backed by the reputable organization KFF (derived […]
The Start-Up Nation’s Cure: A Look at Israeli Healthcare Technology Innovation

As we approach Israel’s 76th birthday on May 15th, we can look back on some of the exceptional achievements made by the Start-up Nation in healthcare, science, and commerce, thanks to the work done here in Israel by universities, institutes, individual scientists, and companies. It’s no secret that Israel punches far above its weight regarding […]
World Obesity Week 2024

As we have highlighted previously, World Obesity Week used to be scheduled in November each year. This year, by consensus of the many governmental and international bodies engaged in public health promotion, it has been moved to March, with the start of Obesity Care Week, which runs from the 4th to the 8th of March. […]
News about health, medicines and treatments – January 2024

The start of 2024 brought exciting news about health, medicines and treatments. Here are three of the most interesting announcements that appeared on news websites in January: Hypertension A study published in one of the leading journals dealing with cardiology brought up some unexpected results. It seems that hypertension may be infectious, in the broadest […]


